Canadian Consensus Conference on hydroxychloroquine.
D018501:Antirheumatic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000378:metabolism; D002170:Canada; D004346:Drug Information Services; D004347:Drug Interactions; D005123:Eye / Q000187:drug effects; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects*; D007774:Lactation / Q000187:drug effects
D018501:Antirheumatic Agents; D006886:Hydroxychloroquine